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The study was designed to evaluate the effect of Citrullus colocynthis pulp hydro-ethanol extract on 
alloxan-induced hyperlipidemia in diabetic rats. 24 albino rats with body weights of 150 to 200 g were 
divided into one control and three experimental groups. Group 1 was the normal control rats, orally 
administered physiological saline. Groups 2, 3 and 4 were diabetic rats orally administered 
physiological saline (diabetic, untreated), glibenclamide (diabetic, GL) or C. colocynthis extract (300 mg 
/kg) (diabetic, CC), respectively. All treatments were administered orally, on a daily basis, for a period of 
30 days. At the end of the experimental period, animals in all the four groups were fasted for 12 h and 
then sacrificed. Blood samples and liver tissues were taken for the determination of total cholesterol, 
triglycerides, free fatty acids and phospholipids. Portions of the liver were homogenized and used for 
determination of lipid peroxidation biomarkers [thiobarbituric acid reactive substances (TBARS) and 
lipid hydroperoxides (HPx)], and for biological antioxidant levels [reduced glutathione (GSH), 
superoxide dismutase (SOD) and catalase (CAT)].  The results show significant decreases in the levels 
of total cholesterol, triglycerides, free fatty acids and phospholipids in serum and liver of C. colocynthis 
treated diabetic rats when compared to diabetic untreated rats.  Also, relative to diabetic untreated rats, 
oral administration of C. colocynthis to diabetic rats significantly reduced elevated levels of liver 
TBARS and HPx to near normal levels and caused significant increases in GSH, SOD and CAT levels, an 
effect that is comparable to but more pronounced than that of glibenclamide. These results indicate that 
C. colocynthis pulp hydro-ethanol extract possesses potent hypolipidemic and antioxidant actions in 
alloxan induced diabetic rats.    
 





Diabetes mellitus (DM) is a syndrome characterized by 
defects in insulin secretion, insulin action or both, 
resulting in impaired metabolism of glucose and other 
energy-yielding fuels such as lipids and protein (Latha 
and Pari, 2004). Thus, DM is by far the most common 
cause of chronic hyperglycemia, and is also associated 
with marked alterations in the concentration of lipids in 
both serum and tissues. Impaired carbohydrate utilization 
leads to increased lipolysis, resulting in hyperlipidemia 
(Morel and Chisolm, 1989). The chronic hyperglycemia of 
diabetes is associated with long term damage, 
dysfunction and failure of various organs (Lyra et al., 
2006). The liver, an insulin-dependent tissue that plays a 
pivotal role in glucose and lipid homeostasis, is severely 
affected by DM. The liver participates in the uptake, 
oxidation, and metabolic conversion of free fatty acids, 
and synthesis of cholesterol, phospholipids, and 







by the liver, and after esterification with glycerol 
phosphate, they are deposited as triglycrides. As a result, 
diabetic liver steatosis develops (Diniz et al, 2006).  
Hyperlipidemia, in part to peroxidation of membrane 
lipids, is associated with microvascular complications 
which constitute the major cause of morbidity and morta-
lity in diabetic patients (Nagappa et al., 2003). Increased 
lipid peroxidation impairs membrane function by de-
creasing membrane fluidity, and by changing the activity 
of membrane-bound enzymes and receptors (Hunt et al. 
1990). In the process of lipid peroxidation, the fatty acid 
side chains of the membrane lipids, especially those con-
taining one or more carbon-carbon double bonds, are oxi-
dized by the action of free radicals to unsta-
ble hydroperoxides. In the presence of metal catalyst, 
these hydroperoxides decompose to form a complex 
mixture of hydrocarbons and cytotoxic aldehydes, such 
as thiobarbituric acid reactive substances (TBARS) inclu-
ding malondialdehyde (MDA) (Halliwell and Gutterridge, 
1984). Under normal conditions, the level of lipid peroxi-
dation and free radicals production is controlled by va-
rious cellular defense mechanisms (scavenging sys-
tems) including non-enzymatic [reduced glutathione 
(GSH)] and enzymatic systems [superoxide dismutase 
(SOD) and catalase (CAT)] (Kajimoto and Kaneto, 2004). 
Normal levels of these antioxidant defense enzymes is 
sufficient for the eradication of free radicals, thus preven-
ting tissue injury and maintaining normal functions of 
organs.  
It has been suggested that a decreased tissue 
antioxidant status is an important factor in tissue damage 
(Ravi et al., 2004).  In DM, increased formation of reac-
tive oxygen species (ROS) is one of the leading factors in 
diabetic complications (Ravi et al., 2004). Indeed, Kakkar 
et al. (1995) claim that all other factors stem from a single 
hyperglycemia-induced process of overproduction of su-
peroxide.  Hyperglycemia initiates non-enzymatic glyca-
tion of proteins accompanied by increased ROS activity 
that contributes to the bimolecular damage in DM (Cam 
et al., 2003). Oxidative stress may be amplified and pro-
pagated by an autocatalytic cycle of metabolic stress, 
tissue damage and cell death, leading to further increase 
in free radical production and depletion of antioxidants 
(Bailey and Day, 1989).                                       
In spite of the universal acceptance of insulin as one of 
the most important therapeutic drugs for the management 
of DM and its complications, efforts are ongoing to find 
substitute therapies. Aside from classical, chemically 
prepared antihyperglycemics, the use of traditional medi-
cinal plants with hypoglycemic effect is gaining popularity, 
worldwide.  More than 400 traditional plant treatments for 
DM have been reported, but only a small number of these 
herbal remedies have received scientific and medical 
evaluation (Ivorra et al., 1989). C. colocynthis 
(Cucurbitaceae), commonly known as "bitter apple", 
"colosynth", "vine-of-Sodom", and  "tumba"  is  a  tropical  




plant that grows abundantly mainly in the Arabian 
countries but also in some other parts of the world.  In 
traditional medicine, this plant has been used to treat 
constipation (Alkofahi et al., 1996), DM (Ziyyat and 
Legssyer, 1997), edema, fever, jaundice, leukemia, bac-
terial infections, cancer and used as an abortifacient 
(Madari and Jacobs, 2004).  
 In our laboratory, we previously reported the 
antihyerglycemic, insulin releasing and hepato-nephro 
protective effects of C. colocynthis pulp extract in alloxan 
induced diabetic rats (Dallak et al., 2009a and b). Lipid 
metabolism and the antioxidant system are known to be 
impaired in diabetes mellitus. This study was therefore 
undertaken to assess possible hypolypidemic and 
antioxidant promoting effects of a water ethanol extract of 
C. colocynthis pulp in alloxan-induced diabetic rats.   
 
 
MATERIALS AND METHODS 
 
Preparation of C. colocynthis pulp extract 
 
One kilogram of fresh C. colocynthis fruits was collected from the 
Aseer area, southwestern Saudi Arabia.  Mature black seeds were 
separated manually from the pulp of the fruits and then the pulp 
was dried and pulverized with a grinder (Moulinex) into a powder in 
preparation for extraction. The powder was extracted in 1 L of 
water-ethanol mixture (80/20, v/v) for 6 h.  This step was repeated 
three times (Dallak et al., 2009b). The filtrate was pooled and 
concentrated under vacuum at tepid temperatures (not exceeding 
50°C) and dissolved in freshly prepared normal saline to a final 
concentration of 300 mg/ ml for further use. 
 
 
Experimental animals  
 
Male albino Wistar rats (150 to 200 g) bred in the Central Animal 
House, Medical College, King Khalid University, were used in this 
study. The animals were fed on rat chow and water, ad libitum.  The 
animals were maintained in their respective groups for 60 days. All 
experiments were conducted in accordance with the National 
Institute of Health's Guide for the care and use of laboratory 
animals (NIH guide for the care and use of laboratory animals, 
Revised DHEW Publication, 1996). The design of the experiments 
was approved by the Physiology Department Research Committee 
of King Khalid University. Diabetes was induced in male Wistar 
albino rats by intraperitoneal administration of alloxan monohydrate 
(150 mg/ kg body weight) (Ananthi et al., 2003), dissolved in normal 
saline. Since alloxan is capable of producing fatal hypoglycemia as 
a result of massive pancreatic insulin release, rats were treated with 
30% glucose solution orally at different time intervals after 6 h of 
alloxan induction and 5% glucose solution was kept in bottles in 
their cages for the next 24 h to prevent hypoglycemia.  After 10 
days, rats with glycosuria (indicated by Benedict's test) and 
hyperglycemia (blood glucose range of 250 to 375 mg/dl) were 
classified as diabetic used in the study. The rats were divided into 
four groups of six animals in each group (n = 6). All treatments were 
given orally using gavage needles in single daily doses. The rats 
were treated for 30 days as follows: Group 1: normal control rats; 
given only normal saline (1 ml /kg); Group 2: diabetic control group; 
given only normal Saline (1 ml/ kg); Group 3: diabetic GL group; 
treated with glibenclamide (600 mg/ kg body wt /day) (22); Group 4: 
diabetic CC group; treated  orally  with  1 ml /kg  of  C.   colocynthis  
 
 











Diabetic + C.c 
(300 mg/kg) 
Cholesterol (mg/dl) 80.7 ± 4.01 102 ± 6.01* 92 ± 5.1* 82 ± 4.5* 
Triglycerides (mg/dl) 45 ± 3.78 69.5 ± 5.22* 55 ± 5.01* 49.6 ± 4.87* 
Free Fatty Acids (µM/L) 2701 ± 352 3422 ±713.3* 3054 ± 622.1* 3030 ± 422* 
Phospholipids (mg/dl) 83 ± 5.6 101.2 ± 7.6* 88.7 ± 5.43* 87 ± 4.99* 
 
Values are given as mean ± SEM for groups of the six rats each. Values are statistically significant* at p<0.05.  
Diabetic rats were compared with the control rats; Citrullus colocynthis (C.c) treated-diabetic rats were compared with diabetic rats; 




pulp extract (300 mg /kg body weight /day). 
 
 
Collection of serum and lipid extraction 
 
At the end of day 30, the rats were subjected to overnight fasting 
and then sacrificed by cervical dislocation. Blood samples were 
collected directly into plain tubes, allowed to clot at room tem-
perature and then centrifuged at 4000 rpm for 10 min to obtain 
serum which was used for lipid profile estimation. The livers were 
dissected out immediately after the rats were killed, washed in ice-
cold saline and patted dry. Lipids were extracted from tissues using 
chloroform-methanol (2:1 by volume) by the method of Folch et al. 
(1957). Dried lipid extracts were re-suspended in 1 ml of saline 
solution (9 g/L NaCl, 1% triton X - 100) and used for the estimation 
of lipid profile.  
All the following parameters were assayed in serum and liver 
tissue; total cholesterol and triglycerides were estimated by the 
methods of Zlatkis et al. (1953) and Foster and Dunn (1973), 
respectively; free fatty acids and phospholipids were analyzed by 




Biochemical assays in liver homogenate 
 
Liver portions were sliced into tiny pieces and homogenized in 
appropriate buffer (pH 7.00) in cold conditions to give 20% 
homogenate (w/v). The homogenate was centrifuged at 1000 rpm 
for 10 min in a cold centrifuge at 4°C. The supernatant was 
separated and used for estimation of TBARS, HPx, GSH, SOD, and 
CAT. The concentration of TBARS in liver homogenates was 
determined by the method of Okhawa (1979).  In brief, the reaction 
mixture contained 0.1 ml of tissue homogenate, 0.2 ml of sodium 
dodecyl sulfate, 1.5 ml of acetic acid and 1.5 ml of aqueous solution 
of thiobarbituric acid (TBA). The pH of 20% acetic acid was pre-
adjusted with 1 M NaOH to 3.5. The mixture was made up to 4 ml 
with distilled water and heated at 95°C for 1 h in a water bath.  After 
cooling, 1 ml of distilled water and 5 ml of a mixture of n-butanol 
and pyridine (15:1) were added and the mixture was shaken 
vigorously on a vortex mixer. The absorbance of the upper organic 
layer was read at 532 nm and values were expressed as mmol/100 
g of tissue.   
The estimation of lipid HPx in liver homogenates was done by the 
method of Jiang (1992) in which 0.1 ml of tissue homogenate 
(supernatant) was treated with 0.9 ml of Fox reagent (88 mg of 
butylated hydroxytoluene, 7.6 mg of Xylenol orange, and 9.8 mg of 
ammonium iron sulfate added to 90 ml of methanol and 10 ml of 
250 mM sulfuric acid) and incubated at 37°C for 30 min. The color 
developed was read at 560 nm and values were expressed as 
mmol/100 g of tissue.   
The GSH content of liver homogenates was measured at 412 nm 
using the method of Sedlak and Lindsay (1968). The homogenate 
was precipitated with 50% trichloracetic acid and then centrifuged 
at 1000 rpm for 5 min. The reaction mixture contained 0.5 ml of the 
supernatant, 2.0 ml of Tris-EDTA buffer (0.2 M; pH 8.9) and 0.1 ml 
of 0.01 M 5.5’-dithio-bis-2-nitrobenzoic acid. The solution was kept 
at room temperature for 5 min, and then read at 412 nm on the 
spectrophotometer. The values were expressed as mmol/100 g of 
tissue.    
Catalase activity in liver homogenates was assayed using 
commercially available catalase activity assay kit (Biovision, K773-
100). One unit of catalase is the amount of catalase that decom-
poses 1.0 µmol of H2O2 per min at pH 4.5 at 25°C. 
 
 
Estimation SOD activity 
 
The activity of SOD in liver homogenates was assayed using 
commercially available sod activity assay kit (Biovision, K335-100). 
One unit of SOD is that which causes 50% inhibition of the rate 
reduction of superoxide anions to produce a water-soluble for-





Results were expressed as the mean value ± SEM. Statistical 
differences between groups were assessed by Student’s t test. 





The effects of C. colocynthis pulp extract on serum and 
liver lipids of the control and experimental rats are sum-
marized in Tables 1 and 2, respectively. Serum and liver 
homogenate levels of cholesterol, free fatty acids, trigly-
cerides, and phospholipids were significantly increaseed 
in diabetic control rats when compared to normal con-
trols. Administration of glibenclamide and C. colocynthis 
pulp extract to diabetic rats significantly reduced these 
high lipid levels in serum and liver bringing them close to 
the corresponding values in the normal controls rats. 
Table 3 shows the concentrations of TBARS, HPx and 
GSH in liver homogenates of the normal control and 
experimental groups of rats. The levels of TBARS and 
HPx in the diabetic control rats  were  significantly  higher 
 
 











Diabetic + C.c 
(300 mg/kg) 
Cholesterol (mg/100 g wet tissue) 344 ± 2.31 530 ± 4.3* 452 ± 4.01* 422 ± 3.6* 
Triglycerides (mg/100 g wet tissue) 349 ± 5.1 665 ± 9.45* 505 ± 6.1* 401 ± 5.7* 
Free fatty acids (mg/100 g wet tissue) 604 ± 3.87 932 ± 8.54* 792 ± 6.34* 702± 3.21* 
Phospholipids (g/100 g wet tissue) 1.54 ± 0.01 2.85± 0.31* 2.01 ± 0.18* 1.76 ± 2.67* 
 
Values are given as mean ± SEM for groups of the six rats each. Values are statistically significant* at p<0.05.  
Diabetic rats were compared with control rats; C. colocynthis (C.c) treated-diabetic rats were compared with diabetic rats; glibenclamide 











Diabetic + C.c 
(300 mg/kg) 
TBARS (mmol/100g of tissue) 0.85 ± 0.01 2.1 ± 0.10* 1.43 ± 0.30* 1.02 ± 0.21* 
Hydroperoxides (mmol/100g of tissue) 70.21 ± 0.83 99.01 ± 1.31* 88.6 ± 0.6* 81.11 ± 0.44* 
Glutathione (mmol/100 g of tissue) 47.1 ± 1.55 20.65 ± 0.88* 38.0 ± 1.44* 40.87 ± 4.0* 
 
Values are given as mean ± SEM for groups of six rats each. Values are statistically significant* at p<0.05. Diabetic rats were compared with 
control rats; C. colocynthis (C.c) treated-diabetic rats were compared with diabetic rats; glibenclamide treated-diabetic rats were compared 




than those of the normal control rats, whereas in diabetic 
rats treated with C. colocynthis pulp extract or gliben-
clamide, these values were restored nearly to the corres-
ponding values in normal controls. Also, the mean 
concentration of GSH in liver homogenates of diabetic 
control rats was significantly reduced, whereas adminis-
tration of C. colocynthis pulp extracts or Glibenclamide 
resulted in a significant increase in GSH level bringing it 
to near normal levels.  The effect was more pronounced 
in rats treated with C. colocynthis. 
Table 4 shows the activities of SOD and CAT in liver 
homogenates of control normal and experimental rats. 
SOD and CAT activities were significantly reduced in 
diabetic control rats when compared to control normal 
rats; however, their levels returned to near normal levels 
in diabetic rats treated with glibenclamide or C. 





Diabetes mellitus remains the most common chronic 
disorder of carbohydrate, fat and protein metabolism. It is 
characterized by chronic and persistent hyperglycemia, 
degenerative vascular changes and neuropathy due to 
completely or partially depleted insulin secretion or 
increaseed insulin resistance (Scheen, 1997).  Apart from 
hyperglycemia, diabetes mellitus (especially Type 1) is 
accompanied by hypercholesterolemia, hyperlipidemia 
and hepatic steatosis (Brixova, 1981). The hypercho-
lesterolemia is a consequence of accelerated fatty acid 
oxidation to acetyl CoA which is the primary substrate for 
cholesterol synthesis. Similarly, the hyperlipidemia asso-
ciated with diabetes mellitus results from accelerated de 
novo hepatic biosynthesis and release of very low density 
lipoprotein (VLDLc) without a corresponding increase in 
its rate of clearance from the blood by lipoprotein lipase 
whose activity is dependent on high insulin: glucagon 
ratio (Brixova, 1981). 
Traditional medicine, especially in developing countries 
uses medicinal plants as a readily available means of 
maintaining good health and treating diseases, including 
DM. (Bhattaram et al., 2002). This trend is on the 
increase with the recent extraction and development of 
several drugs and chemotherapeutics from these medi-
cinal plants (Davis and Granne, 2001).  In our labora-
tories, we earlier reported that the pulp extract of C. 
colocynthis exerted antihyperglycemic and insulin-
releasing effects in alloxan-induced diabetic rats (Dallak 
et al., 2009a and b).  In this study, we demonstrated a 
hypolipidemic effect of C. colocynthis extract in the same 
alloxan-diabetic animal model. Glibenclamide, which was 
used as a positive control in this study, is a prototype of 
the second generation sulfonylurea class of oral hypo-
glycemic agents. Glibenclamide is known to mediate its 
hypoglycemic effect by stimulating insulin release from 
pancreatic β cells, reducing hepatic insulin clearance, 
stimulating the release of somatostatin and suppressing 
the secretion of glucagon (Blumenthal, 1977). 
  Our data in Tables 1 and 2 show significant reductions 
in levels of free fatty acids, triglycerides, total cholesterol 
and phospholipids in the serum and liver of  diabetic  rats  
 
 











Diabetic + C.c 
(300 mg/kg) 
SOD (U/mg of protein) 12.0±1.20 3.2±2.1* 10.32±5.6* 10.16±4.4* 
CAT (U/mg of protein) 76.3± 6.1 34.3±1.55* 65.45±7.4* 63.72±7.0* 
 
 Values are given as mean ± SEM for groups of six rats each. Values are statistically significant* at p<0.05.  
Diabetic rats were compared with control rats; C. colocynthis (C.c) treated-diabetic rats were compared with diabetic rats; 




treated with Citrullus colocynthis, when compared to non 
treated diabetic rats, an effect that is more pronounced 
than that of glibenclamide. A number of mechanisms can 
account for the observed hypolipidemic effect of the 
extract. It could be due to depressed hepatic gluconeo-
genesis; a positive relationship between gluconeogenesis 
and lipogenesis is well documented (Harris and Crabb, 
1982). We previously reported that the pulp extract of C. 
colocynthis has a regulatory effect on gluconeogenetic 
enzymes (Dallak et al., 2009b). In our previous study, the 
activities of the key enzymes of gluconeogenesis 
(glucose 6 phosphate and fructose 1, 6 biphosphatase) 
were found to be decreased in livers of alloxan diabetic 
rats treated with C. colocynthis relative to the activities in 
non-treated diabetic rats.  This effect was explained by 
an increase in insulin secretion from the remaining beta 
cells (Dallak et al., 2009a and b). Thus, C. colocynthis 
extract may induce hypolipidemia through this common 
pathway. 
Lipid peroxide mediated tissue damage has been 
observed in the development of type I and type II DM 
(Feillet et al., 1999).  In this study, we investigated C. 
colocynthis extract-induced changes on the antioxidant 
defense system by estimating TBARS and HPx levels in 
serum and liver of extract treated rats. Our results (Table 
3) show statistically significant increases in levels of 
these lipid peroxidation biomarkers in the livers of 
diabetic control rats. In alloxan-diabetic rats, glucose 
auto-oxidation generates these free radicals and can 
cause lipid peroxidation (Kakkaar et al. (1985); Pari and 
Latha, (2002); Venkateswaran et al. (2002).  In our study, 
liver TBARS and HPx levels were significantly lowered in 
C. colocynthis extract–treated groups compared to dia-
betic normal rats, indicating reduced lipid peroxidation 
mediated tissue damage. This result is expected, being a 
direct consequence of the hypoglycemic effect of the 
extract. 
In vivo, GSH acts as an antioxidant and its level is 
reduced in diabetes mellitus (Lyra et al., 2006).  We 
observed significantly decreased GSH levels in diabetic 
rat livers. Decreased GSH levels represent increased 
utilization due to increased oxidative stress (Anuradha et 
al., 1993).  Increased GSH content in livers of rats treated 
with C. clocynthis may be one important factor 
responsible for inhibition of lipid peroxidation, which could  
explain the decrease in the levels of TBARS and HPx.  
SOD and CAT are the two major scavenging enzymes 
that remove toxic free radicals in vivo. SOD is an 
antioxidant enzyme, which reduces superoxide radicals 
to H2O2 and oxygen. Catalase catalyzes the dismutation 
of H2O2. Previous studies had reported that SOD and 
CAT activities are decreased in diabetes mellitus (Vucic 
et al. (1997); Searle and Wilson (1980), an effect that 
was attributed to accumulation of O
2−
 and H2O2 (Searle 
and Wilson, 1980). Oral administration of C. clocynthis 
extract in our study caused significant increases in the 
levels of these enzymes, either by interfering with their 
biosynthesis or due to the presence of a free radical 
scavenging activity in the extract. Thus, the extract could 
exert a beneficial action against pathological alterations 
caused by the presence of O2, H2O2 and OH
-
.  
In conclusion, this study provides evidence that in 
alloxan induced diabetic rats, C. colocynthis pulp extract 
has a potent hypolipidemic effect, reducing the lipid 
content of both serum and liver.  The extract also 
possesses an antioxidant protective effect on the liver of 
these rats as evidenced by the decrease in the levels of 
lipid peroxidation markers and the increase in the 
enzymatic and non enzymatic components of the 





The author wishes to thank Mr. Mahmoud Alkhateeb and 
Mr. Mohd Abbas (King Khalid University, KKU) for their 
help in the experimental design and performing the 
biochemical measurements, and Dr. Luke Nwoye for 





Alkofahi A, Batshoun R, Owis W, Najib N (1996). Biological activity of 
some Jordanian plants extracts. Fitoterapia, 5: 435-42. 
Ananthi J, Prakasam A, Pugalendi KV (2003). Antihyperglycemic 
activity of eclipta  alba leaf on alloxan-induced diabetic rats. Yale J. 
Biol .Med. 76: 97-102. 
Anuradha CV, Selvam R (1993). Effect of oral methionine on tissue lipid 
peroxidation and antioxidants in alloxan-induced diabetic rats. J. Nutr. 
Biochem.   4: 212-217. 
Bailey J, Day C (1989). Traditional plant medicine as treatments for  
diabetes. Diabètes Care. 12: 553-564.Morel DW, Chisolm GM 







oxidation and cytotoxicity. J. Lipid. Res.,  30: 1827-1834. 
Bhattaram VA., Graefe U, Kohlert C, Veit M, Derendorf H (2002). 
Pharmacokinetics and bioavailability of herbal medicinal products. 
Phytomedicine., 9: 1-36. 
Blumenthal SA (1977). Potentiation of the hepatic action of insulin by 
chlorpropamide. Diabetes. 26: 485-489.  
Brixova E (1981). Experimental and clinical liver steatosis. Folia Fac 
Med. Univ. Comenian. Bratisl. 19: 9-90 (in Slovakian). 
Cam M, Yavuz O, Guven A, Ercan F, Bukan N and Ustundag N (2003). 
Protective effects of chronic melatonin treatment against renal injury 
in streptozotocin-induced diabetic rats. J. Pineal Res., 35:212-220. 
Dallak M, Al-Khateeb M, Abbas M, Elessa R, Al- Hashem F, Bashir N, 
Khalil M (2009). In vivo, Acute, Normo-hypoglycemic, 
Antihyperglycemic Actions of Orally Administered Ethanol Extract of 
Citrullus colocynthis (L.) Schrab. Am. J. Biochem. Biotechnol. 5 (3): 
119-126. 
Dallak M, Bashir N, Abbas M, Elessa R, Haidara M, Khalil M, AL-
Khateeb A M (2009). Concomitant Down Regulation of Glycolytic 
Enzymes, Upregulation of Gluconeogenic Enzymes and Potential 
Hepato-Nephro-Protective Effects Following the Chronic 
Administration of the Hypoglycemic, Insulinotropic Citrullus 
colocynthis Pulp Extract. Am. J. Biochem. Biotechnol. 5 (4): 153-161. 
Davis SN, Granne DK (2001).  "Insulin, oral agents and the 
pharmacology of the  endocrine pancreas”. In: Goodman and 
Gilman’s The Pharmacol. Basis of Therapeutics, Eds. Hardman JG, 
Limbird LE, Gilman AG. New York: McGraw-Hill Co Inc. pp. 1679-
1714. ISBN: 0071124322. 
Diniz YS, Rocha KR, Souza GA, Galhardi GM, Ebaid GX, Rodrigues 
HG, Fihlo JN, Cicogna AC and Novelli EB (2006). Effects of N-
acetylcysteine on sucrose-rich diet-induced hyperglycaemia, 
dyslipidemia and oxidative stress in rats. Eur. J. Pharmacol., 543: 
151- 157. 
Falholt K, Falholt W, Lund B (1973). An easy colorimetric method for 
routine determination of free fatty acids in plasma.  Chem. Acta. 46: 
105-111. 
Feillet Coudray C, Rock E, Coudray C, Grzelkowska K, Azais Braesco 
V, Dardevet  D, Mazur A (1999). Lipid peroxidation and antioxidant 
status in experimental diabetes. Clin. Chem. Acta. 284: 31-43. 
Folch J, Less M and Solane SGH (1957). A simple method for isolation 
and purification of total lipids from animal tissues. J. Biol. Chem; 26: 
497-509. 
Foster LB, Dunn RT (1973). Stable reagents for determination of serum 
triglycerides by colorimetric hantzsch condensation method. Clin. 
Chem. 19:  338-340. 
Halliwell B, Gutterridge JMC (1984). Lipid peroxidation, oxygen radicals, 
cell damage and antioxidant therapy. The Lancet. 1396-1397. 
Harris RA, Crabb DW (1982). "Metabolic interrelationships" In: Textbook 
of Biochem. with Clin. Correlations, Ed. Delvin TM, New York: John 
Wiley and Sons Inc. pp. 531-559 ISBN 0076125443. 
Hunt JV, Smith CCT, Wolff SP (1990). Autooxidative glycosylation and 
possible involvement of peroxides and free radicals in LDL 
modification by glucose. Diabetes, 39: 1420-1424. 
Ivorra D, Paya M, Villar A (1989). Review of natural products and plants 
as potential antidiabetic drugs. J Ethanopharmacol.  27: 243-275. 
Jiang ZY, Hunt JV, Wolff SD (1992). Ferrous ion oxidation in the 
presence of xylenol orange for detection of lipid hydroperoxides in 
















Kajimoto Y, Kaneto H (2004). Role of oxidative stress in pancreatic 
beta-cell dysfunction. Ann. NY. Acad. Sci., 1011: 168-176. 
Kakkaar R, Kalra J, Mantha SV, Prasad K (1995). Lipid peroxidaton and 
acivity of antioxidant enzymes in diabetic rats. Mol. Cellular Biochem. 
151: 113-119. 
Latha M, Pari L (2004) Effect of an aqueous extract of Scoparia dulcis 
on blood glucose, plasma insulin and some polyol pathway enzymes 
in experimental rat diabetes. Brazillian J. Med. Biol. Res. 37: 577-
586. 
Lyra R, Oliveira M, Lins D, Cavalcanti N (2006). Prevention of type 2 
diabetes mellitus. Arq. Bras. Endocrinol. Metabo. 50: 239-249.  
Madari H and Jacobs RS (2004). An analysis of cytotoxic botanical 
formulations used in the traditional medicine of ancient Persia as 
abortifacient. J. Nat. Prods. 67: 1204-1210. 
Morel DW, Chisolm GM (1989). Antioxidant treatment of diabetic rats 
inhibits lipoprotein oxidation and cytotoxicity. J. Lipid. Res.  30:1827- 
1834. 
Nagappa AN, Thakurdesai PA, Venkat Rao N, Jiwan S (2003). 
Antidiabetic activity of Terminalia catappa Linn fruits. J. 
Ethnopharmacol. 88: 45-50. 
National Institute of Health. (1996) Guide for the care and use of 
laboratory animals. Revised DHEW Pub. (NIH), Office of Sci. and 
Health Reports DRR/NIH, Bethesda, MD. 
Okhawa H, Ohigni N, Yagi K (1979). Assay of lipid peroxides in animal 
tissues by thiobarbituric acid reaction. Anal. Biochem. 95: 351. 
Pari L, Latha M (2002). Antidiabetic effect of Cassia auriculata flowers: 
effect on lipid peroxidation in streptozotocin diabetes rats. Pharm. 
Biol. 40: 351-357. 
Ravi K, Ramachandran B, Subramanian S (2004) Effect of Eugenia 
Jambolana seed kernel on antioxidant defense system in 
streptozotocininduced diabetes in rats. Life Sci. 75(22): 2717-2731 
Sedlak J, Lindsay RH (1968). Estimation of total protein bound and non-
protein sulfhydryl groups in tissue with Ellmans reagent. Anal. 
Biochem. 25: 293-98  
Searle AJ, Wilson R (1980). Glutathione peroxide effect of superoxide, 
hydroxyl and bromine free radicals on enzyme activity. Int. J. Radiat.  
Biol. 37: 213-217.  
Scheen JA (1997). Drug treatment of non-insulin dependent diabetes 
mellitus in the 1990s. Achievement and future dev. Drug. 54: 355-
368. 
Venkateswaran S, Pari L, Saravanan G (2002).  Effect of Phaseolus 
vulgaris on  circulatory antioxidants and lipids in rats with 
streptozotocin-induced diabetes. J. Med. Food. 5: 97-103. 
Vucic M, Gavella M, Bozikov V, Ashcroft SJ, Rocic B (1997).  
Superoxide dismutase activity in lymphocytes and 
polymorphonuclear cells of diabetic patients. Eur. J. Clin. Chem. Clin. 
Biochem.35: 517-521. 
Zlatkis A, Zak B, Bogle GJ (1953). A method for the determination of 
serum cholesterol. J. Clin. Med. 41: 486-492. 
Zilversmit DB, Davis A.K (1950). Micro determination of phospholipids 
by TCA precipitation. J. Lab. Clin. Med. 35: 155-161. 
Ziyyat, A, Legssyer A (1997). Phytotherapy of hypertension and 
diabetes in oriental Morocco. J. Ethnopharmacol. 58 (1):45-54. 
 
 
 
 
 
 
 
 
 
